Related Experiment Video
Updated: Sep 14, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Generating Surprisingly Powerful Pharmacology from Chemically Induced Protein Interactions
Stephen M Hinshaw1, Steven M Banik2, Nathanael S Gray1
1Department of Chemical and Systems Biology, ChEM-H, and Stanford Cancer Institute, Stanford School of Medicine, Stanford University, Stanford, California 94305, United States.
Small molecules that induce protein proximity are revolutionizing cellular research and medicine. New therapeutic strategies are emerging, with targeted protein degradation being a key example of this exciting field.
Area of Science:
- Biochemistry
- Chemical Biology
- Molecular Pharmacology
Background:
- Small molecules inducing protein proximity are powerful tools for studying cellular processes.
- Proximity-inducing agents, including biologics, are increasingly used clinically for diverse targets and diseases.
- Targeted protein degradation is a major therapeutic approach driven by proximity-dependent mechanisms.
Purpose of the Study:
- To explore the principles of proximity pharmacology.
- To identify novel therapeutic mechanisms actionable through chemically induced protein interactions.
- To highlight promising areas for future innovation in proximity-based drug discovery.
Main Methods:
- Review of general principles in proximity pharmacology.
- Analysis of current applications and emerging design strategies for proximity-inducing molecules.
- Identification of underexplored biochemical mechanisms for targeted protein interactions.
Main Results:
- Small molecules and biologics that induce protein proximity have significant applications in research and therapy.
- Targeted protein degradation exemplifies a successful proximity-dependent therapeutic strategy.
- Numerous unexplored pharmacological mechanisms exist for chemically induced protein interactions.
Conclusions:
- Proximity pharmacology offers vast potential for developing novel therapeutics.
- Further innovation in design principles and biochemical mechanisms will expand the reach of proximity-based treatments.
- Key areas ripe for innovation include novel protein-protein interaction triggers and degradation pathways.
More Related Videos
10:17Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
Published on: January 14, 2020
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
Related Concept Videos
Protein-protein Interfaces
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Drug-Receptor Bonds
In...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...